Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Novel therapeutic approaches for pediatric diencephalic tumors: improving functional outcomes.

Autor: Cockle JV; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Corley EA; Pediatric and Adolescent Oncology Drug Development Team, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom., Zebian B; Department of Neurosurgery, Kings College Hospital National Health Service (NHS) Trust, London, United Kingdom., Hettige S; Atkinson Morley Neurosurgery Centre, St George's University Hospital National Health Service (NHS) Foundation Trust, London, United Kingdom., Vaidya SJ; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom., Angelini P; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Stone J; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom., Leitch RJ; Department of Ophthalmology, Epsom and St Hellier University Hospitals Trust, Carshalton, United Kingdom., Albanese A; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Department of Pediatric Endocrinology, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom., Mandeville HC; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Department of Radiotherapy, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom., Carceller F; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Pediatric and Adolescent Oncology Drug Development Team, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom., Marshall LV; Department of Neuro-oncology, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Pediatric and Adolescent Oncology Drug Development Team, Children and Young People's Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Oct 10; Vol. 13, pp. 1178553. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023).